{"id": "article-22837_0", "title": "Herpes Simplex Neonatorum -- Continuing Education Activity", "content": "Herpes simplex virus (HSV) infections in the neonatal period continue to be troublesome for practitioners. In the 1970s, the drug vidarabine was introduced, but it was extremely toxic to the neonate, and there was little improvement in outcomes. The development of acyclovir in the 1980s led to significant improvements in the survival of infected infants. Mortality of infants with the disseminated disease has decreased from 85 percent to 29 percent, and patients with central nervous system (CNS) disease has decreased from 50 percent to roughly 4 percent in industrialized countries. This activity reviews the evaluation and management of neonatal herpes and stresses the role of the interprofessional team in the care of affected patients.", "contents": "Herpes Simplex Neonatorum -- Continuing Education Activity. Herpes simplex virus (HSV) infections in the neonatal period continue to be troublesome for practitioners. In the 1970s, the drug vidarabine was introduced, but it was extremely toxic to the neonate, and there was little improvement in outcomes. The development of acyclovir in the 1980s led to significant improvements in the survival of infected infants. Mortality of infants with the disseminated disease has decreased from 85 percent to 29 percent, and patients with central nervous system (CNS) disease has decreased from 50 percent to roughly 4 percent in industrialized countries. This activity reviews the evaluation and management of neonatal herpes and stresses the role of the interprofessional team in the care of affected patients."}
{"id": "article-22837_1", "title": "Herpes Simplex Neonatorum -- Continuing Education Activity", "content": "Objectives: Identify the etiology of neonatal herpes. Describe the evaluation of neonatal herpes. Outline the treatment options available for neonatal herpes. Explain interprofessional team strategies for improving care coordination to advance outcomes for patients with neonatal herpes. Access free multiple choice questions on this topic.", "contents": "Herpes Simplex Neonatorum -- Continuing Education Activity. Objectives: Identify the etiology of neonatal herpes. Describe the evaluation of neonatal herpes. Outline the treatment options available for neonatal herpes. Explain interprofessional team strategies for improving care coordination to advance outcomes for patients with neonatal herpes. Access free multiple choice questions on this topic."}
{"id": "article-22837_2", "title": "Herpes Simplex Neonatorum -- Introduction", "content": "With the development of acyclovir in the 1980s, there was a vast improvement in the overall survival of these infected infants.\u00a0At present, the mortality of infants with disseminated disease has decreased from 85% to 29%, and patients with central nervous system (CNS) disease has decreased from 50% to roughly 4% in industrialized countries. Unfortunately, it\u00a0remains elevated in developing nations.", "contents": "Herpes Simplex Neonatorum -- Introduction. With the development of acyclovir in the 1980s, there was a vast improvement in the overall survival of these infected infants.\u00a0At present, the mortality of infants with disseminated disease has decreased from 85% to 29%, and patients with central nervous system (CNS) disease has decreased from 50% to roughly 4% in industrialized countries. Unfortunately, it\u00a0remains elevated in developing nations."}
{"id": "article-22837_3", "title": "Herpes Simplex Neonatorum -- Etiology", "content": "There are 8 herpes viruses, Herpes simplex virus type 1 (HSV-1), Herpes simplex virus type 2 (HSV-2), Cytomegalovirus (CMV), Epstein-Barr virus (EBV), Varicella-zoster, Human herpesvirus 6 (HHV-6), Human herpesvirus 7 (HHV-7), and human herpesvirus 8 (HHV-8). Herpes simplex neonatorum is the transmission of either HSV-1 or HSV-2 from the mother to child during gestation via the placenta, during delivery via vaginal secretions, or perinatally via direct contact with active lesions.", "contents": "Herpes Simplex Neonatorum -- Etiology. There are 8 herpes viruses, Herpes simplex virus type 1 (HSV-1), Herpes simplex virus type 2 (HSV-2), Cytomegalovirus (CMV), Epstein-Barr virus (EBV), Varicella-zoster, Human herpesvirus 6 (HHV-6), Human herpesvirus 7 (HHV-7), and human herpesvirus 8 (HHV-8). Herpes simplex neonatorum is the transmission of either HSV-1 or HSV-2 from the mother to child during gestation via the placenta, during delivery via vaginal secretions, or perinatally via direct contact with active lesions."}
{"id": "article-22837_4", "title": "Herpes Simplex Neonatorum -- Epidemiology", "content": "The incidence of HSV-1 and HSV-2 has changed over the past few decades. Currently, over one-third of the world\u2019s population has recurrent HSV infection. By age 5, 35% of black children are infected by HSV-1, and 18% of white children are infected. Genital herpes is predominately caused by HSV-2 in the United States; however, in Japan, the predominant cause of genital herpes is caused by HSV-1. [1]", "contents": "Herpes Simplex Neonatorum -- Epidemiology. The incidence of HSV-1 and HSV-2 has changed over the past few decades. Currently, over one-third of the world\u2019s population has recurrent HSV infection. By age 5, 35% of black children are infected by HSV-1, and 18% of white children are infected. Genital herpes is predominately caused by HSV-2 in the United States; however, in Japan, the predominant cause of genital herpes is caused by HSV-1. [1]"}
{"id": "article-22837_5", "title": "Herpes Simplex Neonatorum -- Pathophysiology", "content": "The HSV is a double-stranded DNA virus that is large and has a surrounding lipid envelope.\u00a0The DNA in HSV-1 and HSV-2 have many similarities, thus causing much cross-reactivity in antibody production.\u00a0The virus enters the body through epithelial cells or mucous membranes.\u00a0When it has replicated within the nucleus of the cells, it travels down the axon to the neurons, where it can establish a latent infection.", "contents": "Herpes Simplex Neonatorum -- Pathophysiology. The HSV is a double-stranded DNA virus that is large and has a surrounding lipid envelope.\u00a0The DNA in HSV-1 and HSV-2 have many similarities, thus causing much cross-reactivity in antibody production.\u00a0The virus enters the body through epithelial cells or mucous membranes.\u00a0When it has replicated within the nucleus of the cells, it travels down the axon to the neurons, where it can establish a latent infection."}
{"id": "article-22837_6", "title": "Herpes Simplex Neonatorum -- History and Physical", "content": "The cutaneous findings are scarring, active lesions, hypo, and hyperpigmentation of the skin, cutis aplasia, and macular rashes.\u00a0In the eyes, one may see microphthalmia, retinal dysplasia, optic atrophy, and or chorioretinitis.\u00a0Neurologically one can see microcephaly, encephalomalacia, hydranencephaly, and intracranial calcifications.\u00a0Infants with disseminated disease often present in the first three weeks of life with symptoms of sepsis.\u00a0Multiple organ systems can be affected by this illness, causing\u00a0jaundice, abnormal liver function, hypoglycemia, hypotension, coagulopathy, pneumonia, and even respiratory failure.\u00a0Encephalitis is present 75% of the time in disseminated disease, thus causing seizures.\u00a0\u00a0Rarely do these infants present with vesicular lesions. Death usually results from shock, progressive liver failure, severe coagulopathy, respiratory failure, and progressive neurological deterioration. These infants usually present around the second or third week of life.\u00a0They may initially have a fever, poor feeding, or present with a sudden episode of seizures or apnea.\u00a0Between 60% and 70% of babies classified as having CNS disease have associated skin lesions at some point in the course of their illness.\u00a0Skin, eye, and mouth disease also presents in the second to the third week of life.\u00a0Typical\u00a0vesicular lesions on an erythematous base are the presenting sign.\u00a0Rarely are\u00a0lesions present in the mouth.\u00a0Conjunctivitis is often present and, left untreated, may develop into herpetic keratitis and possibly even corneal blindness.\u00a0SEM has low mortality but reoccurs in 90% of patients. [2]", "contents": "Herpes Simplex Neonatorum -- History and Physical. The cutaneous findings are scarring, active lesions, hypo, and hyperpigmentation of the skin, cutis aplasia, and macular rashes.\u00a0In the eyes, one may see microphthalmia, retinal dysplasia, optic atrophy, and or chorioretinitis.\u00a0Neurologically one can see microcephaly, encephalomalacia, hydranencephaly, and intracranial calcifications.\u00a0Infants with disseminated disease often present in the first three weeks of life with symptoms of sepsis.\u00a0Multiple organ systems can be affected by this illness, causing\u00a0jaundice, abnormal liver function, hypoglycemia, hypotension, coagulopathy, pneumonia, and even respiratory failure.\u00a0Encephalitis is present 75% of the time in disseminated disease, thus causing seizures.\u00a0\u00a0Rarely do these infants present with vesicular lesions. Death usually results from shock, progressive liver failure, severe coagulopathy, respiratory failure, and progressive neurological deterioration. These infants usually present around the second or third week of life.\u00a0They may initially have a fever, poor feeding, or present with a sudden episode of seizures or apnea.\u00a0Between 60% and 70% of babies classified as having CNS disease have associated skin lesions at some point in the course of their illness.\u00a0Skin, eye, and mouth disease also presents in the second to the third week of life.\u00a0Typical\u00a0vesicular lesions on an erythematous base are the presenting sign.\u00a0Rarely are\u00a0lesions present in the mouth.\u00a0Conjunctivitis is often present and, left untreated, may develop into herpetic keratitis and possibly even corneal blindness.\u00a0SEM has low mortality but reoccurs in 90% of patients. [2]"}
{"id": "article-22837_7", "title": "Herpes Simplex Neonatorum -- Evaluation", "content": "Viral culture is the \u201cgold standard\u201d for verification of HSV infection.\u00a0Cultures should be obtained from lesions that are\u00a0scraped or from the mucous membranes and transported to a viral lab on ice. The virus can also be cultured from cerebrospinal fluid (CSF), blood, urine, stool, rectum, oropharynx, and conjunctivae.\u00a0After the virus is inoculated into the cell culture system and grows, it may then be further identified as HSV-1 or HSV-2.\u00a0The greatest viral yield continues to be isolated from intact skin lesions, which are scraped and from the conjunctivae.\u00a0Polymerase chain\u00a0reaction\u00a0(PCR) allows for the rapid diagnosis of HSV in the clinical setting.\u00a0PCR is very accurate, with a reported sensitivity of 80% and an overall specificity\u00a0of 71%.\u00a0 A Tzank smear looks for multinucleated giant cells in any lesion that may be suspicious of HSV. Other laboratory studies may be abnormal but not diagnostic, yet may be suggestive of HSV infection, including leukopenia, thrombocytopenia, elevated liver enzymes, hypoglycemia, and elevated protein in the CSF. [3]", "contents": "Herpes Simplex Neonatorum -- Evaluation. Viral culture is the \u201cgold standard\u201d for verification of HSV infection.\u00a0Cultures should be obtained from lesions that are\u00a0scraped or from the mucous membranes and transported to a viral lab on ice. The virus can also be cultured from cerebrospinal fluid (CSF), blood, urine, stool, rectum, oropharynx, and conjunctivae.\u00a0After the virus is inoculated into the cell culture system and grows, it may then be further identified as HSV-1 or HSV-2.\u00a0The greatest viral yield continues to be isolated from intact skin lesions, which are scraped and from the conjunctivae.\u00a0Polymerase chain\u00a0reaction\u00a0(PCR) allows for the rapid diagnosis of HSV in the clinical setting.\u00a0PCR is very accurate, with a reported sensitivity of 80% and an overall specificity\u00a0of 71%.\u00a0 A Tzank smear looks for multinucleated giant cells in any lesion that may be suspicious of HSV. Other laboratory studies may be abnormal but not diagnostic, yet may be suggestive of HSV infection, including leukopenia, thrombocytopenia, elevated liver enzymes, hypoglycemia, and elevated protein in the CSF. [3]"}
{"id": "article-22837_8", "title": "Herpes Simplex Neonatorum -- Treatment / Management", "content": "They may require intubation and placement on ventilators and or can have severe hypotension requiring volume boluses and pressors\u00a0for blood pressure support. Once they are respiratory,\u00a0neurologically, and hemodynamically stable, one may start appropriate intravenous\u00a0antiviral therapy. Congenital HSV-infected infants still require therapy. Intravenous (IV) acyclovir for 21 days is thought to prevent further replication of the virus and to decrease the number of future outbreaks. CT or MRI of the\u00a0brain should be performed to evaluate the brain for any signs of abnormal\u00a0findings.\u00a0A pediatric ophthalmologist should evaluate for signs of keratitis or optic atrophy.\u00a0Infants with disseminated or CNS disease should be treated with intravenous\u00a0(IV) acyclovir 20 mg/kg/dose every 8 hours for a total of 21 days.\u00a0If CSF is unable to be obtained for culture or PCR, one should err on the side of caution and treat for a full 21 days.\u00a0 Also, at the end of the 21-day treatment, a blood HSV PCR should be sent to ensure the virus has been eliminated.\u00a0Morbidity from disseminated (SEM) disease has dramatically improved with the use of acyclovir.\u00a0 Duration is limited to a 14-day treatment, and a blood HSV PCR should be obtained, and if the results are positive, the infant should be treated for another seven days or until a negative result is obtained.\u00a0In premature infants with HSV disease requiring acyclovir, the dosing interval may need to be increased secondary to their decreased creatinine clearance.\u00a0All patients receiving acyclovir should be followed twice weekly for signs of a low absolute\u00a0neutrophil count, as this occurs in approximately one-fifth of all patients. [4] [5] [6]", "contents": "Herpes Simplex Neonatorum -- Treatment / Management. They may require intubation and placement on ventilators and or can have severe hypotension requiring volume boluses and pressors\u00a0for blood pressure support. Once they are respiratory,\u00a0neurologically, and hemodynamically stable, one may start appropriate intravenous\u00a0antiviral therapy. Congenital HSV-infected infants still require therapy. Intravenous (IV) acyclovir for 21 days is thought to prevent further replication of the virus and to decrease the number of future outbreaks. CT or MRI of the\u00a0brain should be performed to evaluate the brain for any signs of abnormal\u00a0findings.\u00a0A pediatric ophthalmologist should evaluate for signs of keratitis or optic atrophy.\u00a0Infants with disseminated or CNS disease should be treated with intravenous\u00a0(IV) acyclovir 20 mg/kg/dose every 8 hours for a total of 21 days.\u00a0If CSF is unable to be obtained for culture or PCR, one should err on the side of caution and treat for a full 21 days.\u00a0 Also, at the end of the 21-day treatment, a blood HSV PCR should be sent to ensure the virus has been eliminated.\u00a0Morbidity from disseminated (SEM) disease has dramatically improved with the use of acyclovir.\u00a0 Duration is limited to a 14-day treatment, and a blood HSV PCR should be obtained, and if the results are positive, the infant should be treated for another seven days or until a negative result is obtained.\u00a0In premature infants with HSV disease requiring acyclovir, the dosing interval may need to be increased secondary to their decreased creatinine clearance.\u00a0All patients receiving acyclovir should be followed twice weekly for signs of a low absolute\u00a0neutrophil count, as this occurs in approximately one-fifth of all patients. [4] [5] [6]"}
{"id": "article-22837_9", "title": "Herpes Simplex Neonatorum -- Treatment / Management", "content": "After IV treatment, suppressive therapy with oral acyclovir 300 mg/m 2 per dose three times per day for six months. [5]", "contents": "Herpes Simplex Neonatorum -- Treatment / Management. After IV treatment, suppressive therapy with oral acyclovir 300 mg/m 2 per dose three times per day for six months. [5]"}
{"id": "article-22837_10", "title": "Herpes Simplex Neonatorum -- Differential Diagnosis", "content": "Neonatal sepsis Pediatric aphthous ulcers Pediatric chickenpox Pediatric cytomegalovirus infection Pediatric enteroviral infections Pediatric erythema toxicum Pediatric sepsis Zoster", "contents": "Herpes Simplex Neonatorum -- Differential Diagnosis. Neonatal sepsis Pediatric aphthous ulcers Pediatric chickenpox Pediatric cytomegalovirus infection Pediatric enteroviral infections Pediatric erythema toxicum Pediatric sepsis Zoster"}
{"id": "article-22837_11", "title": "Herpes Simplex Neonatorum -- Pearls and Other Issues", "content": "All infants born to mothers with a history of genital HSV have surface and mucosal cultures performed at 24 hours of life and also a blood HSV PCR.\u00a0If these studies are negative, and the infant is asymptomatic, the infant may be discharged with the mother. Infants born to mothers with active genital lesions and having a prior history of HSV, whether it be C-section or vaginal delivery, are to be screened with mucosal \u00a0HSV cultures and blood for HSV PCR.", "contents": "Herpes Simplex Neonatorum -- Pearls and Other Issues. All infants born to mothers with a history of genital HSV have surface and mucosal cultures performed at 24 hours of life and also a blood HSV PCR.\u00a0If these studies are negative, and the infant is asymptomatic, the infant may be discharged with the mother. Infants born to mothers with active genital lesions and having a prior history of HSV, whether it be C-section or vaginal delivery, are to be screened with mucosal \u00a0HSV cultures and blood for HSV PCR."}
{"id": "article-22837_12", "title": "Herpes Simplex Neonatorum -- Enhancing Healthcare Team Outcomes", "content": "An interprofessional team can improve outcomes for infants with disseminated HSV. The involvement of primary care providers, neonatologists, infectious disease, specialty-trained nurses, and pharmacists is recommended. Prompt recognition and treatment are imperative. Nurses administer treatment, monitor patients, and keep the team apprised of patient status. Infectious disease or pediatric pharmacists review medications and check doses. [Level 5]", "contents": "Herpes Simplex Neonatorum -- Enhancing Healthcare Team Outcomes. An interprofessional team can improve outcomes for infants with disseminated HSV. The involvement of primary care providers, neonatologists, infectious disease, specialty-trained nurses, and pharmacists is recommended. Prompt recognition and treatment are imperative. Nurses administer treatment, monitor patients, and keep the team apprised of patient status. Infectious disease or pediatric pharmacists review medications and check doses. [Level 5]"}
{"id": "article-22837_13", "title": "Herpes Simplex Neonatorum -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Herpes Simplex Neonatorum -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}